Evidence map›Paper›PMID 35355055›Full record

ArticleBrain : a journal of neurology2022

Profiling PI3K-AKT-MTOR variants in focal brain malformations reveals new insights for diagnostic care.

Filomena Pirozzi, Matthew Berkseth, Rylee Shear, Lorenzo Gonzalez, Andrew E Timms, Josef Sulc, Emily Pao, Nora Oyama, Francesca Forzano, Valerio Conti and 14 more

Erratum issuedOpen access · bronzeAbstract read
In one paragraph

Article in Brain : a journal of neurology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
2.9field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 53 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. NEAT1 Promotes Epileptogenesis in Tuberous Sclerosis Complex.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  5. Apigenin Regulating PI3K/AKT Pathway to Improve Depressive Behavior in Epileptic Rats.Combinatorial chemistry & high throughput screening · 2026
    Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Developmental and epileptic encephalopathies.Nature reviews. Disease primers · 2024
    Review
  16. Review
  17. Article
  18. Somatic Mosaicism inNeurology. Genetics · 2024
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

24 authors at 8 institutions in 3 countries.

Filomena PirozziCenter for Integrative Brain Research, Seattle Children's Research Institute, Seattle, WA, USA.
Matthew BerksethCenter for Integrative Brain Research, Seattle Children's Research Institute, Seattle, WA, USA.
Rylee ShearCenter for Integrative Brain Research, Seattle Children's Research Institute, Seattle, WA, USA.
Lorenzo GonzalezJohns Hopkins University School of Medicine, Baltimore, MD, USA.
Andrew E TimmsCenter for Integrative Brain Research, Seattle Children's Research Institute, Seattle, WA, USA.
Josef SulcCenter for Integrative Brain Research, Seattle Children's Research Institute, Seattle, WA, USA.
Emily PaoCenter for Integrative Brain Research, Seattle Children's Research Institute, Seattle, WA, USA.
Nora OyamaCenter for Integrative Brain Research, Seattle Children's Research Institute, Seattle, WA, USA.
Francesca ForzanoDepartment of Clinical Genetics, Guy's and St Thomas NHS Foundation Trust and King's College London, London, UK.
Valerio ContiPediatric Neurology, Neurogenetics and Neurobiology Unit and Laboratories, Children's Hospital A. Meyer-University of Florence, Italy.
Renzo GuerriniPediatric Neurology, Neurogenetics and Neurobiology Unit and Laboratories, Children's Hospital A. Meyer-University of Florence, Italy.
Emily S DohertySection of Clinical Genetics, Carilion Clinic Children's Hospital, Roanoke, VA, USA.
Sulagna C SaittaDivision of Medical Genetics, Department of Obstetrics and Gynecology, David Geffen School of Medicine at the University of California Los Angeles, Los Angeles, CA, USA.
Christina M LockwoodDepartment of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, USA.
Colin C PritchardDepartment of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, USA.
William B DobynsDivision of Genetics and Metabolism, Department of Pediatrics, University of Minnesota, Minneapolis, MN, USA.ORCID 0000-0002-7681-2844
Edward NovotnyCenter for Integrative Brain Research, Seattle Children's Research Institute, Seattle, WA, USA.
Jason N N WrightDepartment of Radiology, Seattle Children's Hospital, Seattle, WA, USA.
Russell P SanetoCenter for Integrative Brain Research, Seattle Children's Research Institute, Seattle, WA, USA.
Seth FriedmanCenter for Clinical and Translational Research, Seattle Children's Hospital, Seattle, WA, USA.
Jason HauptmanDepartment of Neurological Surgery, University of Washington, Seattle, WA, USA.
Jeffrey OjemannDepartment of Neurological Surgery, University of Washington, Seattle, WA, USA.
Raj P KapurDepartment of Laboratories, Seattle Children's Hospital, Seattle, WA, USA.
Ghayda M MirzaaCenter for Integrative Brain Research, Seattle Children's Research Institute, Seattle, WA, USA.
Seattle Children's Hospital · USUniversity of Washington · USMeyer Children's Hospital · ITCarilion Clinic · USJohns Hopkins University · USKing's College London · GBUniversity of California, Los Angeles · USUniversity of Minnesota · US

Funding

Mechanisms of Brain Dysmorphology in MN1 C-Terminal Truncation Syndrome, a Novel Intellectual Developmental Disability Disorder P50HD103524 · NICHD · UNIVERSITY OF WASHINGTON · PI Sandra E Juul · 2020 to 2026
$9.9M
Megalencephaly and segmental brain overgrowth in humansR01NS092772 · NINDS · SEATTLE CHILDREN'S HOSPITAL · PI MILLEN, KATHLEEN JOYCE · 2015 to 2019
$3.3M
NICHD NIH HHS P50 HD103524NINDS NIH HHS R01 NS092772
6 · The paper itself

Abstract

Focal malformations of cortical development including focal cortical dysplasia, hemimegalencephaly and megalencephaly, are a spectrum of neurodevelopmental disorders associated with brain overgrowth, cellular and architectural dysplasia, intractable epilepsy, autism and intellectual disability. Importantly, focal cortical dysplasia is the most common cause of focal intractable paediatric epilepsy. Gain and loss of function variants in the PI3K-AKT-MTOR pathway have been identified in this spectrum, with variable levels of mosaicism and tissue distribution. In this study, we performed deep molecular profiling of common PI3K-AKT-MTOR pathway variants in surgically resected tissues using droplet digital polymerase chain reaction (ddPCR), combined with analysis of key phenotype data. A total of 159 samples, including 124 brain tissue samples, were collected from 58 children with focal malformations of cortical development. We designed an ultra-sensitive and highly targeted molecular diagnostic panel using ddPCR for six mutational hotspots in three PI3K-AKT-MTOR pathway genes, namely PIK3CA (p.E542K, p.E545K, p.H1047R), AKT3 (p.E17K) and MTOR (p.S2215F, p.S2215Y). We quantified the level of mosaicism across all samples and correlated genotypes with key clinical, neuroimaging and histopathological data. Pathogenic variants were identified in 17 individuals, with an overall molecular solve rate of 29.31%. Variant allele fractions ranged from 0.14 to 22.67% across all mutation-positive samples. Our data show that pathogenic MTOR variants are mostly associated with focal cortical dysplasia, whereas pathogenic PIK3CA variants are more frequent in hemimegalencephaly. Further, the presence of one of these hotspot mutations correlated with earlier onset of epilepsy. However, levels of mosaicism did not correlate with the severity of the cortical malformation by neuroimaging or histopathology. Importantly, we could not identify these mutational hotspots in other types of surgically resected epileptic lesions (e.g. polymicrogyria or mesial temporal sclerosis) suggesting that PI3K-AKT-MTOR mutations are specifically causal in the focal cortical dysplasia-hemimegalencephaly spectrum. Finally, our data suggest that ultra-sensitive molecular profiling of the most common PI3K-AKT-MTOR mutations by targeted sequencing droplet digital polymerase chain reaction is an effective molecular approach for these disorders with a good diagnostic yield when paired with neuroimaging and histopathology.

Indexed as

Drug Resistant EpilepsyEpilepsyHemimegalencephalyMalformations of Cortical DevelopmentBrainChildClass I Phosphatidylinositol 3-KinasesHumansMutationPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktTOR Serine-Threonine KinasesClass I Phosphatidylinositol 3-KinasesMTOR protein, humanPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktTOR Serine-Threonine KinasesddPCRepilepsyfocal cortical dysplasiahemimegalencephalymosaicism

Identifiers

PMID35355055
PMCPMC9630661
OpenAlexW4205911223

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.